Kidney disease is one of the strongest medical drivers of insomnia and sleep disorders, with an estimated half to three-quarters of people in kidney failure reporting insomnia symptoms and a range of other sleep problems affecting even those in earlier stages of the disease.1PubMed Central. Common Sleep Disorders in Patients With Chronic Kidney Disease: A Systematic Review on What They Are and How We Should Treat Them The connection is not just one of discomfort keeping you awake. Chronic kidney disease (CKD) disrupts the body’s internal clock, floods the brain with waste products that interfere with sleep regulation, shifts fluid into places that collapse the airway, and triggers restless legs and relentless itching. The result is a cluster of sleep disorders that overlap and reinforce each other in ways that make treatment genuinely difficult.
How Common Sleep Problems Are Across the Stages of Kidney Disease
Sleep complaints are not limited to people on dialysis. Even in the early stages of CKD, somewhere between 8% and 36% of patients report insomnia symptoms, a rate that climbs sharply as kidney function declines.1PubMed Central. Common Sleep Disorders in Patients With Chronic Kidney Disease: A Systematic Review on What They Are and How We Should Treat Them By the time someone reaches end-stage kidney disease and requires dialysis, the prevalence of sleep disorders is strikingly high. One study of hemodialysis patients found that over 80% had poor sleep quality.2PubMed Central. Quality of Sleep and its Relationship to Quality of Life in Hemodialysis Patients The sleep problems people experience are varied: insomnia with trouble falling or staying asleep, restless legs syndrome, obstructive sleep apnea, central sleep apnea, and excessive daytime sleepiness that impairs work and daily functioning. Despite how common these issues are, they remain under-recognized in clinical practice, often overshadowed by more immediately life-threatening aspects of kidney disease.3Nature Reviews Nephrology. Sleep disorders in chronic kidney disease
Why Failing Kidneys Wreck Sleep
The mechanisms linking kidney disease to sleep disruption are layered. They are not one clean pathway but several simultaneous biological problems acting on the brain, the nervous system, and the body’s fluid balance.
Uremic Toxins and Brain Chemistry
Healthy kidneys filter waste products from the blood. As kidney function deteriorates, these waste products, collectively called uremic toxins, build up. These toxins do not just sit passively in the bloodstream. They cross into the brain and disrupt neural pathways involved in sleep regulation, altering neurotransmitter levels and contributing to cognitive impairment and psychological symptoms that all feed into poor sleep.4Kidney Research and Clinical Practice. Dreams disrupted: a comprehensive review of sleep disorders in chronic kidney disease This toxic burden explains why sleep problems worsen as kidney function declines, and why standard dialysis, which removes only some uremic toxins a few times per week, does not fully resolve the issue.
Melatonin Suppression and a Broken Body Clock
Melatonin is the hormone your brain releases in the evening to signal that it is time to sleep. In kidney disease, that evening melatonin surge becomes progressively weaker as kidney function drops. A study measuring melatonin rhythms across different stages of CKD found that kidney filtration rate was significantly correlated with both the size of the nightly melatonin rise and total melatonin production. By the time patients reach hemodialysis, the nocturnal melatonin rise can be essentially absent.5Nephrology Dialysis Transplantation. Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study) Without that hormonal cue, the body loses a central signal for when to feel sleepy, making it harder to fall asleep and reducing overall sleep quality.6PubMed Central. Circadian Influences on Chronic Kidney Disease Progression: Molecular Signaling Pathways of Melatonin and Their Therapeutic Potential
Chronic Inflammation
CKD is an inflammatory condition, and the elevated levels of inflammatory molecules circulating in the blood appear to have their own independent effect on sleep. Research in people with chronic kidney failure found that elevated TNF, one of the body’s main inflammatory signals, was likely involved in blocking melatonin production.7PubMed. Analyses of melatonin, cytokines, and sleep in chronic renal failure Another inflammatory molecule, IL-1 beta, has been specifically linked to sleep complaints in hemodialysis patients.8PubMed. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients So inflammation does double damage: it disrupts sleep directly through brain signaling and indirectly by suppressing melatonin.
Restless Legs and Relentless Itching
Two of the most sleep-destroying symptoms of advanced kidney disease are restless legs syndrome and uremic pruritus (severe itching caused by kidney failure). These deserve separate attention because they are among the most treatable drivers of insomnia in CKD, and many patients experience them without realizing there is a specific condition causing their sleeplessness.
Restless legs syndrome (RLS) produces an irresistible urge to move the legs, typically worsening in the evening and at night. In CKD, it is driven by problems with dopamine metabolism in the brain, worsened by iron deficiency and the uremic state.3Nature Reviews Nephrology. Sleep disorders in chronic kidney disease The result is that just as you are trying to fall asleep, your legs feel like they need to be in motion. It is a profoundly frustrating experience that makes both falling asleep and staying asleep difficult.
Uremic pruritus, on the other hand, is severe itching that affects a large proportion of dialysis patients. The itching tends to be worst at night. Research has found that sleep quality deteriorates significantly as pruritus severity increases, with patients reporting substantially worse scores on standardized sleep measures as their itching worsens.9PubMed Central. Uremic pruritus: prevalence, determinants, and its impact on health-related quality of life and sleep in Indian patients undergoing hemodialysis It is easy to underestimate itching as a sleep disruptor, but anyone who has been kept awake by it understands how it fragments the night into short stretches of restless dozing.
There is some good news here. Gabapentin, given at much lower doses than are typically used for other conditions, has been shown to reduce both RLS symptoms and pruritus in people with CKD. Even starting doses equivalent to 50 to 100 milligrams daily produced significant improvement, though side effects occurred in a notable proportion of patients.10PubMed. Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease For people whose insomnia is primarily driven by these two symptoms, addressing them directly can be more effective than trying to treat the insomnia itself.
Sleep Apnea and the Fluid Shift Problem
Sleep apnea is surprisingly common in kidney disease, and its mechanism in CKD is different from how it typically develops in the general population. The usual picture of obstructive sleep apnea involves excess weight around the throat narrowing the airway. In kidney disease, there is an additional process at work: overnight fluid redistribution.
When you lie down to sleep, gravity stops holding excess fluid in your legs. In people with healthy kidneys, this is not a big deal, the kidneys adjust. But in CKD, where the body often retains too much fluid, that fluid shifts upward toward the neck and chest overnight. As it accumulates in the soft tissues around the throat, it narrows the airway and produces or worsens obstructive sleep apnea. Research in end-stage kidney disease patients confirmed that the change in leg fluid volume overnight correlated with both the increase in neck circumference and the severity of obstructive sleep apnea.11Nephrology Dialysis Transplantation. Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea The more fluid that migrated upward from the legs overnight, the worse the sleep apnea.12PubMed. Targeting volume overload and overnight rostral fluid shift: A new perspective to treat sleep apnea
Central sleep apnea, where the brain temporarily stops sending the signal to breathe rather than the airway physically collapsing, also occurs at higher rates in CKD. This is thought to be driven in part by the metabolic acidosis (excess acid in the blood) that occurs in advanced kidney disease. The acidosis makes the brain’s breathing control center overly sensitive, so small fluctuations in blood carbon dioxide levels can push it below the threshold that triggers a breath, leading to pauses.13Saudi Journal of Kidney Diseases and Transplantation. Pathophysiology of Central Sleep Apnea in Chronic Kidney Disease Many CKD patients have a mix of both obstructive and central apnea events, making diagnosis and treatment more complex than typical sleep apnea.
The fluid-shift mechanism has a practical treatment implication. When researchers used ultrafiltration (aggressive fluid removal) in dialysis patients with sleep apnea, the apnea-hypopnea index dropped by nearly 50%, and the overnight deterioration in heart function that accompanied the sleep apnea was eliminated.14Karger. Effect of Ultrafiltration on Sleep Apnea and Cardiac Function in End-Stage Renal Disease This underscores that for CKD patients, managing fluid balance is not just about swelling in the legs or blood pressure; it is directly relevant to whether you can breathe properly while you sleep.
Anxiety, Depression, and the Vicious Cycle
Kidney disease takes a heavy psychological toll. Living with a chronic, progressive illness that requires demanding treatment regimens, dietary restrictions, and frequent medical visits creates fertile ground for anxiety and depression. Both of these conditions are independently powerful sleep disruptors, and in CKD they pile on top of the biological mechanisms already making sleep difficult.
Research in hemodialysis patients has consistently identified anxiety and depression as independent predictors of both insomnia severity and overall poor sleep quality.15PubMed Central. The Interplay of Anxiety, Depression, Sleep Quality, and Socioeconomic Factors in Somali Hemodialysis Patients The relationship runs in both directions: poor sleep worsens anxiety and depression, which in turn makes sleep worse, creating a self-reinforcing cycle that is difficult to break.16PubMed Central. Correlation analysis of anxiety, depression, and sleep quality in end-stage renal disease patients undergoing maintenance hemodialysis Depression appears to have a somewhat stronger association with poor sleep quality than anxiety does, though both contribute meaningfully. This cycle means that treating sleep in isolation, without addressing the psychological burden, is likely to have limited success. And treating depression or anxiety alone, without addressing the biological sleep disruptors from the kidney disease itself, is equally incomplete.
Treating Sleep Disorders in Kidney Disease
The conventional first-line treatment for insomnia in the general population is cognitive behavioral therapy for insomnia (CBT-I), and there are reasons to expect it might help CKD patients as well. An early pilot trial in peritoneal dialysis patients found that CBT improved sleep quality, reduced fatigue, and even lowered inflammatory cytokine levels.17PubMed. Cognitive-behavioral therapy for sleep disturbance in patients undergoing peritoneal dialysis: a pilot randomized controlled trial That was an encouraging signal.
However, a more rigorous randomized trial comparing CBT-I, trazodone (a commonly prescribed sleep medication), and placebo in hemodialysis patients found that neither CBT-I nor trazodone performed meaningfully better than placebo over 7 or 25 weeks. All three groups improved by a similar amount, with insomnia severity scores dropping by roughly 3 to 5 points regardless of group assignment.18PubMed. Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis: A Randomized Clinical Trial This is a sobering finding. It suggests that the standard toolkit for insomnia may not be enough when the underlying biology is this disrupted. The insomnia in CKD is not just a behavioral or psychological problem that responds to better sleep habits; it has deep metabolic and physiological roots that CBT-I does not address.
Medication choices are also complicated by the kidney disease itself. The kidneys are a primary route for eliminating many drugs from the body, so medications that are safe at normal doses in people with healthy kidneys can accumulate to dangerous levels in CKD.19SpringerLink / Advances in Therapy. Psychotropic drugs and renal failure: translating the evidence for clinical practice This limits the sleep medications that can be safely used, often requiring much lower doses and more careful monitoring than usual.
Changing the Dialysis Schedule
One of the more promising approaches targets the disease process itself by changing how dialysis is delivered. Nocturnal hemodialysis, in which patients undergo treatment at home while they sleep on most nights, rather than sitting in a clinic three times a week, has shown real benefits. Switching from conventional hemodialysis to nocturnal hemodialysis reduced apnea-hypopnea episodes from an average of about 25 to 8 per hour of sleep.20PubMed. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis A meta-analysis confirmed significant reductions in the apnea-hypopnea index with this approach, particularly in patients who already had sleep disorders, though the picture for subjective sleep quality was more mixed, with only observational studies (not randomized trials) showing clear improvement in how patients felt about their sleep.21PLOS ONE. Effect of nocturnal hemodialysis on sleep parameters in patients with end-stage renal disease: a systematic review and meta-analysis
The logic behind this approach makes sense: longer and more frequent dialysis sessions do a better job of clearing uremic toxins, managing fluid balance, and correcting metabolic acidosis, all of which are driving the sleep problems. But nocturnal home hemodialysis is not accessible to everyone. It requires training, home setup, and a level of support that many patients do not have available.
What Happens to Sleep After a Kidney Transplant
Perhaps the strongest evidence that kidney disease itself causes these sleep problems is what happens when the disease is effectively cured. After successful kidney transplantation, restless legs syndrome symptoms have been reported to disappear within days. One follow-up study found that RLS vanished within 1 to 21 days after transplant, and patients whose transplanted kidneys continued functioning well remained free of RLS for up to 9 years of follow-up.22PubMed. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation A separate study confirmed that RLS frequency in transplant recipients was markedly lower than in dialysis patients, attributing the improvement to normalization of uremia, along with improvements in psychological symptoms and sleep disturbances.23PubMed. Effect of Renal Transplantation in Restless Legs Syndrome
The speed of improvement after transplant is telling. If the sleep problems were primarily caused by years of accumulated damage to the brain’s sleep centers, you would not expect them to resolve within days. The rapid reversal suggests that the ongoing biochemical environment of kidney failure, the uremic toxins, the fluid overload, the disrupted melatonin, is the active cause, and removing it lets the body’s sleep machinery recover quickly.
The Relationship Runs Both Ways
The connection between kidney disease and sleep disorders is not a one-way street. Sleep apnea appears to worsen kidney disease in return. A large study that stratified patients by sleep apnea severity found that roughly 29% of those with moderate obstructive sleep apnea and 31% of those with severe obstructive sleep apnea had a moderate-to-very-high risk of CKD progression, compared to about 14% of those with no or mild sleep apnea. After adjusting for established kidney disease risk factors, having moderate sleep apnea nearly tripled the odds of being at elevated risk for kidney disease progression, and severe sleep apnea carried similar odds.24PubMed Central. Risk of chronic kidney disease in patients with obstructive sleep apnea
The proposed mechanisms for this reverse pathway include the repeated drops in blood oxygen that occur with each apnea episode, which trigger inflammation and oxidative stress that damage the kidneys over time. This bidirectional relationship means that ignoring sleep disorders in CKD patients may allow a feedback loop in which kidney function deteriorates faster, which worsens the sleep disorders further, which accelerates kidney decline. Breaking that cycle with appropriate sleep disorder treatment could potentially slow kidney disease progression, though this has not yet been conclusively demonstrated in clinical trials.
Sleep and Quality of Life on Dialysis
Poor sleep quality is not just unpleasant for dialysis patients; it correlates with worse outcomes across nearly every dimension of quality of life. Research has found significant negative associations between global sleep quality scores and physical health, the burden of kidney disease on daily life, mental health, social support, and sexual function.2PubMed Central. Quality of Sleep and its Relationship to Quality of Life in Hemodialysis Patients People who sleep badly feel worse physically, withdraw more socially, and report their disease as more burdensome. Insomnia in earlier-stage CKD also accelerates disease progression and increases mortality risk in dialysis patients.1PubMed Central. Common Sleep Disorders in Patients With Chronic Kidney Disease: A Systematic Review on What They Are and How We Should Treat Them Sleep is not a secondary concern in CKD management; it is intertwined with how quickly the disease progresses and how bearable daily life feels along the way.
Children and Adolescents With Kidney Disease
Sleep disruption from kidney disease is not limited to adults. Children and adolescents with CKD face an elevated risk of sleep-related disorders as well, with research showing roughly seven and a half times the odds of having a sleep-related disorder compared to healthy peers.25PubMed. Sleep disorders and executive function in children and adolescents with chronic kidney disease The consequences for younger patients may be particularly significant. In children, the same study found that sleep-related breathing disorders and insomnia mediated the effect of CKD on metacognition, the higher-order thinking skills involved in planning, organizing, and self-monitoring. In practical terms, CKD was disrupting these children’s sleep, and the disrupted sleep was impairing their ability to think and learn. Behavioral regulation difficulties, on the other hand, appeared to be a more direct consequence of having CKD regardless of sleep quality. For parents of children with kidney disease, this means sleep problems are worth pursuing aggressively, not just because the child is tired, but because the sleep disruption may be actively undermining cognitive development during critical years.